Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Net revenues
Total revenues	$ 11,426	$ 14,681
Cost of revenues (excluding amortization of acquired intangible assets)
Cost of revenues	3,554	1,640
Research and development	3,728	5,843
Selling, general and administrative	14,262	14,028
Amortization of acquired intangible assets	368	546
Total operating expenses	21,912	22,057
Loss from operations	(10,486)	(7,376)
Other income (expense):
Interest income	76	110
Interest expense	(2,437)	(1,148)
Change in fair value of warrant liabilities	242	(8,875)
Change in fair value of debt	(12)	81
Loss on debt extinguishment	(5,736)	(3,908)
Other expense, net	(1,401)	(897)
Total other expense	(9,268)	(14,637)
Loss before income taxes	(19,754)	(22,013)
Income tax expense (benefit)
Net loss	(19,754)	(22,013)
Other comprehensive loss
Change in fair value of debt due to change in credit risk, net of tax	5
Comprehensive loss	(19,749)	(22,013)
Deemed dividend relating to inducement of Dragasac warrants	(64)
Net loss attributable to common shareholders	$ (19,813)	$ (22,013)
Per share information:
Net loss per share - basic	$ (0.84)	$ (1.03)
Net loss per share - diluted	$ (0.84)	$ (1.03)
Weighted average shares outstanding - basic	23,530,877	21,440,980
Weighted average shares outstanding - diluted	23,530,877	21,440,980
Product [Member]
Net revenues
Total revenues	$ 9,018	$ 12,843
Cost of revenues (excluding amortization of acquired intangible assets)
Cost of revenues	2,506	1,222
Service [Member]
Net revenues
Total revenues	1,408	1,287
Cost of revenues (excluding amortization of acquired intangible assets)
Cost of revenues	209	177
License Royalty and Other [Member]
Net revenues
Total revenues	1,000	551
Cost of revenues (excluding amortization of acquired intangible assets)
Cost of revenues	$ 839	$ 241